Sfoglia per RIVISTA
CANCER RESEARCH
Collezione ASL Asti

  

Items : 1

Targeting CD38 and PD-1 with isatuximab (Isa) plus cemiplimab (Cemi) in patients (pts) with advanced malignancies: Results from a Phase 1/2 open-label, multicenter study in Cancer Research

2021
ASL Asti

Wang R; Loumagne L; De Bono J; Dong Y; Chiron M; Abbadessa G; Lee H; Shen Y-C; Perrino M; Meng R; Gutierrez M; Pant S; Daniele G; Greystoke A; Su W-C; Massard C; Saleh M; Italiano A; Iacovelli R; Carthon B; Bauer TM; Tucci M; Lin C-C; Zucali P;